Pacific Health Care Organization Inc. (PFHO): The 15-20% reference is specific to G&A,...

Reply Private New

Replies (3) Next 10 Prev Next

Send PM Follow Ignore

Re: Rawnoc post# 789

Wednesday, 06/04/2014 5:07:56 PM

Wednesday, June 04, 2014 5:07:56 PM

The 15-20% reference is specific to G&A, which was just 10% of overall opex last Q.

Keep Last Read

Replies (3) Next 10 Prev Next

Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/07/2024 05:43:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/08/2024 01:06:13 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/31/2024 11:42:28 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2024 12:49:08 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/24/2024 12:52:29 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/20/2024 10:00:13 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2024 09:08:41 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 10:24:32 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/22/2023 09:58:55 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 05:58:45 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2023 04:45:16 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/28/2023 07:29:42 PM
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 09/28/2023 07:28:42 PM

InvestorsHub NewsWire

FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM

FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM

Only $200 per official company press release!